{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of Bilateral Deep Brain Stimulation of the Fornix in Mild, Probable Alzheimer\u2019s Disease"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The ADvance Trial is a multicenter, 12-month, double-blind, randomised, controlled feasibility study."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients with mild, probable AD, recruited between June 6, 2012, and April 28, 2014."
      },
      "Intervention": {
        "score": 2,
        "evidence": "A total of 42 patients were randomised to receive bilateral fornix DBS."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to assess the safety, efficacy, and tolerability of bilateral deep brain stimulation (DBS) of the fornix in patients with mild, probable Alzheimer\u2019s disease (AD)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the 90-day perioperative safety of the procedure."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted at the patient level, with allocation concealment ensured."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was maintained for outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 42 patients were randomised to receive bilateral fornix DBS."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Twenty-six patients (61.9%) experienced 64 AEs related to the study procedure, with 7 serious AEs in 5 patients (11.9%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Twenty-six patients (61.9%) experienced 64 AEs related to the study procedure, with 7 serious AEs in 5 patients (11.9%)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 19,
    "max_score": 25
  },
  "model": "gpt-4o"
}